Skip to content

Clinical Pharmacist-led Appropriate Acid Suppression Therapy Stewardship Program

Impact of Clinical Pharmacist-led Appropriate Acid Suppression Therapy Stewardship Program on Hospitalized Older Patients: A Non-Randomized Controlled Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05113667
Enrollment
250
Registered
2021-11-09
Start date
2019-09-01
Completion date
2021-08-31
Last updated
2023-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Geriatric

Brief summary

To evaluate the impact of clinical pharmacist-led appropriate acid suppression therapy stewardship program in hospitalized older patients.

Detailed description

This prospective, nonrandomized controlled study was conducted in older patients who ordered proton pump inhibitor (PPI) at admission in an internal medicine service of tertiary training and research hospital. In the intervention group, clinical pharmacist-led services (including medication reconciliation and medication review) were conducted during hospitalization and at discharge by using the guidelines and potentially inappropriate medications (PIM) criteria \[American Geriatric Society-AGS Beers Criteria©, 2019\]. Medication Appropriateness Index (MAI), inappropriate PPI cost, and hospitalization for gastrointestinal bleeding within 1 year after discharge were calculated in both groups

Interventions

OTHERClinical Pharmacist-led Appropriate Acid Suppression Therapy Stewardship Program

Clinical pharmacist provided medication reconciliation and medication review during the hospital stay.

Sponsors

Marmara University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

* 65 years old or greater * Admitted to the hospital with any reason * Ordered at least one PPI dose within 48 hours of admission

Exclusion criteria

* Transferred to another ward (including an intensive care unit) * Having active gastrointestinal bleeding * Having active malignity

Design outcomes

Primary

MeasureTime frameDescription
Appropriateness of Proton Pump Inhibitors Usageduring hospital stay, an average of 14 daysThe rate of appropriateness use of proton pump inhibitors based on the guidelines at hospital stay
Potentially Inappropriate Proton Pump Inhibitors Usageat discharge, an average of 14 days after admission to hospitalThe rate of potentially inappropriate use of proton pump inhibitors based on American Geriatric Society Beers Criteria© 2019

Secondary

MeasureTime frameDescription
Medication Appropriateness Index for Proton Pump Inhibitors at hospital stayduring hospital stay, an average of 14 daysMedication Appropriateness Index (MAI); included 10 items. Each item was weighted from 1-3. The highest score per medication was 18. Higher scores of this index represent more inappropriateness of each medication.
Clinical outcome1 yearThe number of patients who hospitalized for bleeding within 1 year after discharge
Medication Appropriateness Index for Proton Pump Inhibitors at dischargeat discharge, an average of 14 days after admission to hospitalMedication Appropriateness Index (MAI); included 10 items. Each item was weighted from 1-3. The highest score per medication was 18. Higher scores of this index represent more inappropriateness of each medication.
Cost saving after dischargea monthMedication cost for potentially inappropriate PPI after discharge
Cost saving during hospital stayduring hospital stay, an average of 14 daysMedication cost for inappropriate PPI during hospital study

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026